January 24, 2025
Researchers have identified novel retinal vascular signatures that are significantly associated with the risk for a first stroke. When combined with age and sex, these retinal […]
January 24, 2025
A significant portion of patients with multiple sclerosis (MS) can achieve a stable disease state when treated with modern disease-modifying therapy (DMT), especially when started early […]
January 24, 2025
TOPLINE: The use of anti–calcitonin gene-related peptide monoclonal antibodies (anti-CGRP mAbs) was not linked to increased risk for a cardiovascular disease (CVD) event in a cohort […]
January 24, 2025
In a recent study, beta blockers appeared to significantly lower both the annualized risk for conversion from presymptomatic to symptomatic Huntington’s disease (HD) and the rate […]
January 22, 2025
The US Food and Drug Administration (FDA) has added a boxed warning to the label of multiple sclerosis drug glatiramer acetate about the risk of anaphylaxis. From […]
January 17, 2025
TOPLINE: There is no link between antibiotic use and an increased risk for dementia or cognitive impairment in healthy adults aged ≥ 70 years, a new […]
January 16, 2025
Higher intake of processed red meat, including bacon, hot dogs, and bologna, is associated with a significantly elevated risk for cognitive decline and dementia, results of […]
January 16, 2025
Modern disease-modifying drugs (DMTs) have revolutionized the treatment of relapsing-remitting multiple sclerosis (MS). However, their use during pregnancy has long been concerning. A study published in […]
January 15, 2025
In 2022, the Journal of Neurosurgery took the unusual step of publishing a case report of a nonhuman subject, in this case an 8-year-old male sea […]